1.Expert Survey on Managing Safety Events in Sleep Laboratory
Kyung Wook KANG ; Hyun Goo KANG ; Myeong-Kyu KIM ; Ki-Young JUNG ;
Journal of Sleep Medicine 2024;21(1):20-27
		                        		
		                        			
		                        			 An increasing number of studies have highlighted the impact of sleep on physical and mental health and a corresponding rise in public interest; numbers of polysomnography (PSG) examinations have correspondingly increased. However, research and recommendations concerning safety events that may occur during PSG are lacking. This study aimed to investigate the current status of safety events in sleep laboratories in Korea and gather expert opinions on this matter. Methods: We conducted a web-based survey of Korean sleep experts to explore their opinions on safety events in sleep laboratories. Results: All Korean sleep experts who participated in this study agreed on the need for guidelines concerning safety events that can occur during PSG. Through this survey, they provided insights into the cardiac and pulmonary safety events that may arise during PSG. Conclusions: This study can assist sleep physicians in managing safety events in sleep laboratories currently, and in the future, it may contribute to the development of guidelines for handling safety events during PSG. 
		                        		
		                        		
		                        		
		                        	
2.Delayed Development of Symptomatic Arterial Stenosis after a Mechanical Thrombectomy for an Acute Embolic Occlusion of the Middle Cerebral Artery
Minju KIM ; Joong-Goo KIM ; Myeong Ju KOH ; Jay Chol CHOI
Journal of the Korean Neurological Association 2022;40(1):47-50
		                        		
		                        			
		                        			 Delayed stenosis of the treated artery following mechanical thrombectomy is known to occur in approximately 10% of the patients after the procedure. It is usually asymptomatic, and was frequently found within 1 year after the procedure. Here we report a 58-year-old stroke patient who suffered from recurrent transient ischemic attacks due to a delayed stenosis of the middle cerebral artery 2 years after the mechanical thrombectomy for an abrupt embolic occlusion of the vessel. 
		                        		
		                        		
		                        		
		                        	
4.Effectiveness and Influencing Factors of Percutaneous Transluminal Angioplasty for Stenosis of Transposed Brachiobasilic Arteriovenous Fistula
Dahye SHIN ; Yong Jae KIM ; Seung Boo YANG ; Jae Myeong LEE ; Woong Hee LEE ; Dong Erk GOO
Journal of the Korean Radiological Society 2019;80(3):477-489
		                        		
		                        			 PURPOSE:
		                        			To evaluate effectiveness of percutaneous transluminal angioplasty (PTA) for transposed brachiobasilic arteriovenous fistula (tBBAVF), and to analyze the factors influencing patency after PTA.
		                        		
		                        			MATERIALS AND METHODS:
		                        			In 101 patients who underwent operation for tBBAVF from January 2006 to February 2008, we identified 42 patients undergoing PTA. We conducted a retrospective analysis of sequential PTAs in these patients from 2006 to 2017.
		                        		
		                        			RESULTS:
		                        			A total of 100 PTAs were performed. The technical success rate was 93% and the clinical success was 100%. Only ruptures occurred in 12% as minor complications. Primary patency rate was 61%, 29%, 7%, and secondary patency was 91%, 82%, 59% at 6, 12, and 24 months, respectively. Primary patency rate was lower in tBBAVF with rupture (p = 0.024). Secondary patency rate was significantly lower in the diabetes (p = 0.002).
		                        		
		                        			CONCLUSION
		                        			Repetitive PTAs in tBBAVF are acceptable due to excellent secondary patency. Primary patency of tBBAVF is low in patients with rupture. Diabetes itself has a significant effect on secondary patency. 
		                        		
		                        		
		                        		
		                        	
5.Clinical Outcomes of Elderly Patients with Non ST-Segment Elevation Myocardial Infarction Undergoing Coronary Artery Bypass Surgery
Woo Jin KIM ; Myung Ho JEONG ; Dong Goo KANG ; Seung Uk LEE ; Sang Ki CHO ; Youngkeun AHN ; Young Jo KIM ; Chong Jin KIM ; Myeong Chan CHO ;
Chonnam Medical Journal 2018;54(1):41-47
		                        		
		                        			
		                        			The aim of this study is to investigate the clinical outcomes of the elderly patients with Non ST-segment elevation myocardial infarction (NSTEMI) undergoing coronary artery bypass surgery (CABG) compared to non-elderly patients. Patients with NSTEMI and undergoing CABG (n=451) who were registered in the Korea Acute Myocardial Infarction Registry between December 2003 and August 2012 were divided into two groups.; the non-elderly group ( < 75 years, n=327) and the elderly group (≥75 years, n=124). In-hospital mortality was higher in the elderly group (4.9% vs. 11.3%, p=0.015), but cardiac death, myocardial infarction, and major adverse cardiovascular events (MACE) including cardiac death, myocardial infarction, percutaneous revascularization, and redo-CABG after a one-year follow up were not different between the two groups. Predictors of in-hospital mortality in patients with NSTEMI undergoing CABG were left ventricular (LV) dysfunction (ejection fraction ≤40%) [hazard ratio (HR): 2.76, 95% confidence interval (CI): 1.16–6.57, p=0.022] and age (HR: 1.05, 95% CI: 1.01–1.10, p=0.047). So elderly NSTEMI patients should be considered for CABG if appropriate, but careful consideration for surgery is required, especially if the patients have severe LV systolic dysfunction.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Coronary Artery Bypass
		                        			;
		                        		
		                        			Coronary Vessels
		                        			;
		                        		
		                        			Death
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Hospital Mortality
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Myocardial Infarction
		                        			
		                        		
		                        	
6.Magnetic nanoparticle based purification and enzyme-linked immunosorbent assay using monoclonal antibody against enrofloxacin.
Nam Gun KIM ; Myeong Ae KIM ; Young Il PARK ; Tae Sung JUNG ; Seong Wan SON ; Byungjae SO ; Hwan Goo KANG
Journal of Veterinary Science 2015;16(4):431-437
		                        		
		                        			
		                        			Monoclonal anti-enrofloxacin antibody was prepared for a direct competitive enzyme-linked immunosorbent assay (ELISA) and purification system using monoclonal antibody (mAb) coupled magnetic nanoparticles (MNPs). The IC50 values of the developed mAb for enrofloxacin (ENR), ciprofloxacin, difloxacin, sarafloxacin, pefloxacin, and norfloxacin were 5.0, 8.3, 9.7, 21.7, 36.0, and 63.7 ng/mL, respectively. The lowest detectable level of ENR was 0.7 ng/mL in the prepared ELISA system. To validate the developed ELISA in the food matrix, known amounts of ENR were spiked in meat and egg samples at 10, 20 and 30 ng/mL. Recoveries for ENR ranged from 72.9 to 113.16% with a coefficient of variation (CV) of 2.42 to 10.11%. The applicability of the mAb-MNP system was verified by testing the recoveries for ENR residue in three different matrices. Recoveries for ENR ranged from 75.16 to 86.36%, while the CV ranged from 5.08 to 11.53%. Overall, ENR-specific monoclonal antibody was prepared and developed for use in competitive to ELISAs for the detection of ENR in animal meat samples. Furthermore, we suggest that a purification system for ENR using mAb-coupled MNPs could be useful for determination of ENR residue in food.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Ciprofloxacin
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay*
		                        			;
		                        		
		                        			Inhibitory Concentration 50
		                        			;
		                        		
		                        			Meat
		                        			;
		                        		
		                        			Nanoparticles*
		                        			;
		                        		
		                        			Norfloxacin
		                        			;
		                        		
		                        			Ovum
		                        			;
		                        		
		                        			Pefloxacin
		                        			
		                        		
		                        	
7.Differential Prognostic Impacts of Diabetes over Time Course after Acute Myocardial Infarction.
Hack Lyoung KIM ; Si Hyuck KANG ; Chang Hwan YOON ; Young Seok CHO ; Tae Jin YOUN ; Goo Yeong CHO ; In Ho CHAE ; Hyo Soo KIM ; Shung Chull CHAE ; Myeong Chan CHO ; Young Jo KIM ; Ju Han KIM ; Youngkeun AHN ; Myung Ho JEONG ; Dong Ju CHOI
Journal of Korean Medical Science 2013;28(12):1749-1755
		                        		
		                        			
		                        			This study was performed to evaluate the effects of diabetes on short- and mid-term clinical outcomes in patients with acute myocardial infarction (AMI). Between October 2005 and December 2009, a total of 22,347 patients with AMI from a nationwide registry was analyzed. At the time point of the day 30 after AMI onset, landmark analyses were performed for the development of major adverse cardiovascular events (MACEs), including death, re-infarction and revascularization. In this cohort, 6,131 patients (27.4%) had diabetes. Short-term MACEs, which occurred within 30 days of AMI onset, were observed in 1,364 patients (6.1%). Among the 30-day survivors (n = 21,604), mid-term MACEs, which occurred between 31 and 365 days after AMI onset, were observed in 1,181 patients (5.4%). After adjustment for potential confounders, diabetes was an independent predictor of mid-term MACEs (HR, 1.25; 95% CI, 1.08-1.45; P = 0.002), but not of short-term MACEs (HR: 1.16; 95% CI: 0.93-1.44; P = 0.167). Diabetes is a poor prognostic factor for mid-term clinical outcomes but not for short-term outcomes in AMI patients. Careful monitoring and intensive care should be considered in diabetic patients, especially following the acute stage of AMI.
		                        		
		                        		
		                        		
		                        			Acute Disease
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Cardiovascular Diseases/etiology
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/complications/*diagnosis
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Myocardial Infarction/*diagnosis/epidemiology/mortality
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Proportional Hazards Models
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Survival Analysis
		                        			;
		                        		
		                        			Time Factors
		                        			
		                        		
		                        	
8.Aberrant Ovarian Artery Arising from the Common Iliac Artery: Case Report.
Won Kyung KIM ; Seung Boo YANG ; Dong Erk GOO ; Yong Jae KIM ; Yun Woo CHANG ; Jae Myeong LEE
Korean Journal of Radiology 2013;14(1):91-93
		                        		
		                        			
		                        			A 46-year-old Vietnamese woman received embolization therapy in order to control postpartum hemorrhage. Angiography revealed an aberrant ovarian artery arising from the right common iliac artery. Superselective catheterization and subsequent embolization of the aberrant ovarian artery and bilateral uterine arteries were performed. Precise knowledge of the anatomic variations of the ovarian artery is important for successful embolization.
		                        		
		                        		
		                        		
		                        			Angiography
		                        			;
		                        		
		                        			Embolization, Therapeutic/*methods
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Iliac Artery/*radiography
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Ovary/*blood supply/*radiography
		                        			;
		                        		
		                        			Postpartum Hemorrhage/*radiography/*therapy
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Vascular Malformations/*radiography/*therapy
		                        			
		                        		
		                        	
9.Long Working Hours and Emotional Well-Being in Korean Manufacturing Industry Employees.
Kyoung Hye LEE ; Jong Eun KIM ; Young Ki KIM ; Dong Mug KANG ; Myeong Ja YUN ; Shin Goo PARK ; Jae Seok SONG ; Sang Gil LEE
Annals of Occupational and Environmental Medicine 2013;25(1):38-
		                        		
		                        			
		                        			OBJECTIVES: Korea is well known for its long work hours amongst employees. Because workers of the manufacturing industry are constantly exposed to extended work hours, this study was based on how long work hours affect their emotional well-being. METHODS: The analysis was done using the secondary Korean Working Condition Survey (KWCS). Long work hours were defined to be more than 48 hours, and they were subcategorized into units of 52 hours and 60 hours. Based on the WHO (five) well-being index, emotional state was subdivided into three groups - reference group, low-mood group, and possible depression group- where 28 points and 50 points were division points, and two groups were compared at a time. Association between long work hours and emotional state was analyzed using binary and multinomial logistic regression analysis. RESULTS: Working for extended working hours in the manufacturing industry showed a statistically significant increase (t test p < 0.001) in trend among the possible depression group when compared to the reference group and the low-mood group. When demographical characteristics, health behaviors, socioeconomic state, and work-related characteristics were fixed as controlled variables, as work hours increased the odds ratio of the possible depression group increased compared to the reference group, and especially the odds ratio was 2.73 times increased for work hours between 48-52 and 4.09 times increased for 60 hours or more and both were statistically significant. In comparing the low-mood group and possible depression group, as work hours increased the odds ratio increased to 1.73, 2.39, and 4.16 times, and all work hours from working 48-52 hours, 53-60 hours, and 60 hours or more were statistically significant. Multinomial logistic regression analysis also showed that among the reference group and possible group, the possible depression group was statistically significant as odds ratio increased to 2.94 times in working 53-60 hours, and 4.35 times in 60 hours or more. CONCLUSIONS: Long work hours have an adverse effect on emotional well-being. A more diversified research towards variables that affect long work hours and emotional well-being and how they interact with each other and their relationship to overall health is imperative.
		                        		
		                        		
		                        		
		                        			Depression
		                        			;
		                        		
		                        			Health Behavior
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Odds Ratio
		                        			
		                        		
		                        	
10.Safety and Efficacy of Overlapping Homogenous Drug-Eluting Stents in Patients with Acute Myocardial Infarction: Results from Korea Acute Myocardial Infarction Registry.
Khurshid AHMED ; Myung Ho JEONG ; Rabin CHAKRABORTY ; Young Joon HONG ; Doo Sun SIM ; Sumera AHMED ; Seung Hwan HWANG ; Min Goo LEE ; Keun Ho PARK ; Ju Han KIM ; Youngkeun AHN ; Myeong Chan CHO ; Chong Jin KIM ; Young Jo KIM ; Jong Chun PARK ; Jung Chaee KANG
Journal of Korean Medical Science 2012;27(11):1339-1346
		                        		
		                        			
		                        			The aim of this study was to compare safety and efficacy of 4 homogenous overlapping drug-eluting stents (DES) in acute myocardial infarction (AMI) patients. We selected 1,349 consecutive patients (62.1 +/- 14.9 yr, 69.4% male) who received homogenous overlapping DESs in diffuse de novo coronary lesions from Korea Acute Myocardial Infarction Registry from April 2006 through September 2010. They were divided into 4 groups based on type of DES implanted - Paclitaxel (PES), Sirolimus (SES), Zotarolimus (ZES) and Everolimus (EES)-eluting stents. Primary endpoint was 12-month MACE. We also studied EES versus other DESs (PES + SES + ZES). Mean stent length was 26.2 +/- 7.5 mm and mean stent diameter was 3.1 +/- 0.4 mm. Average number of stents used per vessel was 2.2 +/- 0.5. Incidence of major adverse cardiac events (MACE) in PES, SES, ZES, and EES groups were 9.5%, 9.2%, 7.5%, and 3.8%, respectively (P = 0.013). In EES group, overall MACE and repeat revascularization were lowest, and no incidence of stent thrombosis was observed. Non-fatal MI was highest in PES, almost similar in SES and EES with no incidence in ZES group (P = 0.044). Cox proportional hazard analysis revealed no differences in the incidence of primary endpoint (P = 0.409). This study shows no significant differences in 12-month MACE among 4 groups.
		                        		
		                        		
		                        		
		                        			Acute Disease
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Antineoplastic Agents, Phytogenic/adverse effects/*therapeutic use
		                        			;
		                        		
		                        			Coronary Angiography
		                        			;
		                        		
		                        			Drug-Eluting Stents/*adverse effects
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents/adverse effects/*therapeutic use
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Myocardial Infarction/*drug therapy/mortality/pathology
		                        			;
		                        		
		                        			Myocardial Revascularization
		                        			;
		                        		
		                        			Paclitaxel/adverse effects/therapeutic use
		                        			;
		                        		
		                        			Proportional Hazards Models
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Sirolimus/adverse effects/analogs & derivatives/therapeutic use
		                        			;
		                        		
		                        			Survival Analysis
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail